What Is the Current Scenario of the Immunotherapy Drugs Market?

1. Growing Adoption of Targeted Therapy Driving Immunotherapy Drugs Market © P&S Intelligence. All rights reserved Page 1

2. In 2017, the global immunotherapy drugs market reached a value of $106.1 billion and is predicted to advance at a 13.6% CAGR during the forecast period (2018–2023). The market is growing because of the rising availability of biosimilars, surging prevalence of chronic diseases, increasing implementation of target therapy, and rising demand and development of mAbs. Immunotherapy is the treatment of a disease by enhancing, inducing, or suppressing an immune response for fighting against infection and disease. In terms of type, the immunotherapy drugs market is bifurcated into vaccines and checkpoint inhibitors. Between these, the checkpoint inhibitors division held the largest share of the immunotherapy drugs market during the historical period (2013–2017) and is expected to dominate the market during the forecast period. Checkpoint inhibitors are preferred for the treatment of chronic diseases, since they offer better and effective treatment results. These drugs act directly on the site of action without delaying the effect of the medicine, which is why they are increasingly being adopted. On the basis of brand, the division is further classified into Enbrel, Remicade, Herceptin, Rituxan/MabThera, Humira, and others. Receive Sample Copy of this Report:https://www.psmarketresearch.com/market- analysis/immunotherapy-drugs-market/report-sample When therapy area is taken into consideration, the immunotherapy drugs market is categorized into infectious diseases, cancer, and autoimmune and inflammatory diseases. Out of these, the cancer category accounted for the major share of the market during the historical period and is projected to contribute the largest revenue share to the market during the forecast period as well, owing to the rising prevalence of cancer across the world. The autoimmune & inflammatory diseases category is predicted to grow at the fastest pace during the forecast period. Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry- url=immunotherapy-drugs-market Another primary factor which is contributing significantly to the growth of the immunotherapy drugs market is the rising implementation of target therapy. Targeted treatment provides various health benefits to the patients, which is why the adoption of these therapies is increasing. Healthcare providers are making use of targeted treatment for treating different chronic diseases, including cystic fibrosis, melanoma, leukemia, and lung cancer. For example, Herceptin drug is utilized as a targeted therapy for the treatment of adenocarcinoma of the stomach or gastroesophageal junction and breast cancer. Hence, the market is being driven by the increase in the implementation of target therapy and rising prevalence of chronic diseases. © P&S Intelligence. All rights reserved Page 2

3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved Page 3